Influence of Healthcare-Associated Factors on the Efficacy of Hepatitis C Therapy

Influence of Healthcare-Associated Factors on the Efficacy of Hepatitis C Therapy

Hepatitis C infection is a complex entity associated with sizable morbidity and mortality, with great social and economic consequences that put a heavy potential burden on healthcare systems allover the world. Despite the great improvement of hepatitis C virus (HCV) therapy and its high clinica...

Full description

Bibliographic Details
Main Authors:	Mohamed A. Daw, Aghynya A. Dau, Mohamed M. Agnan
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	The Scientific World Journal
Online Access:	http://dx.doi.org/10.1100/2012/580216

Similar Items

Hepatitis C Virus in North Africa: An Emerging Threat
by: Mohamed A. Daw, et al.
Published: (2016-01-01)

Hepatitis C Virus in Arab World: A State of Concern
by: Mohamed A. Daw, et al.
Published: (2012-01-01)

The geographic variation and spatiotemporal distribution of hepatitis C virus infection in Libya: 2007–2016
by: Mohamed A. Daw, et al.
Published: (2018-11-01)

Epidemiological manifestations of hepatitis C virus genotypes and its association with potential risk factors among Libyan patients
by: Daw Mohamed A, et al.
Published: (2010-11-01)

Libyan healthcare system during the armed conflict: Challenges and restoration
by: Mohamed A. Daw
Published: (2017-06-01)

Importance of adherence for efficacy of hepatitis C combined therapy
by: Nožić Darko, et al.
Published: (2013-01-01)

The influence of HLA in chronic hepatitis B and C and analysis of a new subtype of hepatitis C virus
by: Mohamed, Ajayeb Dakhelallah
Published: (1996)

Evaluation of factors associated with relapse in telaprevir-based triple therapy for chronic hepatitis C
by: C Kondo, et al.
Published: (2016-01-01)

Occult hepatitis B infection in egyptian chronic hepatitis C patients: prevalence, impact on pegylated interferon/ribavirin therapy
by: Mohamed Lamiaa A, et al.
Published: (2010-11-01)

Virus-Host Interaction during Therapy against Hepatitis C Virus
by: Abdel-Hakeem, Mohamed S.
Published: (2009)

The influence of hepatic steatosis on the success of antiviral therapy for chronic hepatitis C
by: Preveden Tomislav, et al.
Published: (2017-01-01)

Modulation of immune surface molecules associated with the efficacy of antiviral therapy for chronic hepatitis C virus infection
by: Ya-Ling Wei, et al.
Published: (2006)

Interferon-ribavirin therapy for chronic hepatitis C: Efficacy in Saudi patients
by: Sandokji Abdulkareem, et al.
Published: (2003-01-01)

The efficacy of direct-acting antiviral therapy in patients with chronic hepatitis C
by: Irina RUSU, et al.
Published: (2020-03-01)

Virus-Host Interaction during Therapy against Hepatitis C Virus
by: Salah Eldin Abdel Hakeem, Mohamed
Published: (2009)

Hepatitis C in healthcare personnel: secondary data analysis of therapies with direct-acting antiviral agents
by: Claudia Westermann, et al.
Published: (2018-05-01)

Seroprevalence of the hepatitis C virus in healthcare personnel of the IMSS
by: L.C. Ramírez-Zamudio, et al.
Published: (2021-10-01)

Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection
by: Hussien Ahmed, et al.
Published: (2017-03-01)

Hepatitis C Virus Infection at Primary Healthcare Level in Abha City, Southwestern Saudi Arabia: Is Type 2 Diabetes Mellitus an Associated Factor?
by: Suliman M. Al Humayed, et al.
Published: (2018-11-01)

Impact of occult hepatitis B virus infection on antiviral therapy in chronic hepatitis C patients
by: Gamal El Din Ahmed Elsawaf, et al.
Published: (2015-09-01)

NS34A resistance-associated substitutions in chronic hepatitis C in Upper Egypt and regression of liver fibrosis after direct-acting antiviral therapy
by: Nahed A. Makhlouf, et al.
Published: (2021-02-01)

THE EFFICACY OF HEPATITIS B VACCINE IN HEMOPHILIC PATIENTS WITH HEPATITIS C VIRAL INFECTION
by: H HOUR FAR, et al.
Published: (2003-12-01)

The Epidemiology of Hepatitis D Virus in North Africa: A Systematic Review and Meta-Analysis
by: Mohamed A. Daw, et al.
Published: (2018-01-01)

Hepatitis G Virus Infection in Patients with Hepatitis C
by: Heba S. Selim, et al.
Published: (2010-09-01)

Influence of the inflammatory response on treatment of hepatitis C with triple therapy
by: Fernanda Cristina Winckler, et al.

Frequent transient hepatitis C viremia without seroconversion among healthcare workers in Cairo, Egypt.
by: Aline Munier, et al.
Published: (2013-01-01)

Libyan armed conflict 2011: Mortality, injury and population displacement
by: Mohamed A. Daw, et al.
Published: (2015-09-01)

Efficacy and safety of immunosuppressive therapy in the treatment of seronegative hepatitis associated aplastic anemia
by: Chen HF, et al.
Published: (2014-09-01)

Factors associated with treatment interruption for hepatitis C
by: Luciana Oliveira de Rezende Melo, et al.
Published: (2014-02-01)

The grapefruit flavonoid naringenin as a Hepatitis C virus therapy : efficacy, mechanism and delivery
by: Goldwasser, Jonathan
Published: (2010)

Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
by: Waleed Seif Eldin Mohamed Mostafa, et al.
Published: (2020-01-01)

Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: Seroprevalence, risk factors and related chronic liver diseases
by: Hala I. Mohamed, et al.
Published: (2013-06-01)

Hepatitis B in healthcare workers: prevalence, vaccination and relation to occupational factors
by: Luiz A.S. Ciorlia, et al.

Hepatitis C virus-associated membranoproliferative glomerulonephritis treated with directly acting antiviral therapy
by: S Nayak, et al.
Published: (2018-01-01)

Porphyria cutanea tarda in a hemodialysis patient with hepatitis C virus: Efficacy of treatment with multiple phlebotomies and erythropoietin
by: Mohamed Amine Hamzi, et al.
Published: (2013-01-01)

Prevalence and Associated Factors of Hepatitis C in Self-introduced Substance Abusers
by: A Azizi, et al.
Published: (2011-02-01)

Prevalence and Associated Factors of Hepatitis C in Self-introduced Substance Abusers
by: A Azizi, et al.
Published: (2011-04-01)

What factors influence the progression of hepatitis C virus infection?
by: Wright, M.
Published: (2004)

Immunosuppressive therapy in autoimmune hepatitis : efficacy and toxicity
by: Dhaliwal, Harpreet K.
Published: (2018)

Clinical course and efficacy of antiretroviral therapy of combined bloodborne pathology: human immunodeficiency virus and chronic hepatitis C
by: L. A. Kravchenko
Published: (2017-06-01)

Cannot write session to /tmp/vufind_sessions/sess_cimvs26oc50u8d9mdu52llvv01